Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Ampoule 10 X 10 ml |
|
Dosage
For adult patients and children from 11 years of age,the recommended daily dosage is 10 ml (one ampoule).
For full details see prescribing information.
Indications
VITALIPID N ADULT is indicated in adult patients and children from 11 years of age as a supplement in intravenous nutrition to meet the daily requirements of thefat-solublevitaminsA,D2,EandK1.
Contra-Indications
Hypersensetivity to egg-, soy- or peanut- protein or to any of the active substances or excipients.
Special Precautions
This medical product contains soya-bean oil and egg phospholipids, which may rarely cause allergic reactions. Cross allergic reactions have been observed between soya-bean and peanut. This priduct must not be given undiluted.
Side Effects
No adverse effects related to this product have been reported.
Drug interactions
The presence of trace elements may cause some degradation of vitamin A. Retinol(vitaminA)maybebrokendownbyexposuretoultravioletlight. Vitamin K1 interacts with anticoagulants of the coumarin type.
Pregnancy and Lactation
Animal reproduction studies or clinical investigations during pregnancy have not been made with VITALIPID N ADULT. There are, however, published reports on safe administration of fat-soluble vitamins in this patient group.
However, the intake of more than 8000 IU of Vitamin A is not recommended during pregnancy due to the risk of birth defects.
Overdose
Overdoses of fat-soluble vitamins may lead to toxicity syndromes, but there is no evidence of any toxicity at the dosages recommended.
No adverse effects of a single overdose of fat-soluble vitamins should occur. No specific treatment is needed.
After prolonged infusion of an overdose of Vitamin D, elevated serum concentrations of Vitamin D metabolites may occur. This may cause osteopenia. Rapid infusion of Vitamin K1 in colloid water solution may provoke flushing, bronchospasm, tachycardia and hypotension.
This has not been reported after infusions of this product.